Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK
NCT01715792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 587
Last updated 2014-02-10
Summary
This study aims to assess the risk of solid organ transplant (SOT) rejection following vaccination with Pandemrix™ and/ or seasonal influenza vaccination.
Conditions
Interventions
- OTHER
-
Data collection
Data extraction from the CPRD GOLD and HES, and additional data obtained from complementary information provided by the GPs using a standardised questionnaire.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom
NCT00996853 ·Status: COMPLETED
-
H1N1sw Vaccine in Adult Transplant Recipients
NCT01069601 ·Status: TERMINATED ·Phase: PHASE2
-
Improved Novel VaccIne CombinaTion InflUenza Study
NCT03300362 ·Status: TERMINATED ·Phase: PHASE2
-
Seasonal Flu Vaccine in Adult Transplant Recipients
NCT01258023 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects
NCT00606359 ·Status: COMPLETED ·Phase: PHASE2
-
Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy
NCT00402805 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
NCT02623075 ·Status: COMPLETED
-
Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population
NCT00306995 ·Status: COMPLETED ·Phase: PHASE2
-
Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients
NCT00760175 ·Status: COMPLETED ·Phase: NA
-
Influenza Vaccine in Lung Transplant Patients
NCT00205270 ·Status: COMPLETED
-
Early Flu Shots in SOT
NCT03327987 ·Status: WITHDRAWN
-
Reducing the Burden of Influenza After Solid-Organ Transplantation
NCT03699839 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children
NCT00502593 ·Status: COMPLETED ·Phase: PHASE2
-
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
NCT04530786 ·Status: COMPLETED
-
Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)
NCT02567721 ·Status: COMPLETED
-
Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
NCT04531787 ·Status: COMPLETED
-
Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients
NCT01254955 ·Status: COMPLETED
-
High Dose vs. Standard Influenza Vaccine in Adult SOT
NCT03139565 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients
NCT02104869 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults
NCT00603811 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1
NCT01623518 ·Status: COMPLETED ·Phase: PHASE1
-
Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.
NCT01808456 ·Status: COMPLETED ·Phase: PHASE4
-
Swine Flu (Novel Influenza A H1N1) Vaccine Study
NCT00980850 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
NCT03061955 ·Status: COMPLETED
-
Influenza Vaccine in Pediatric Transplant Subjects
NCT00133510 ·Status: COMPLETED ·Phase: PHASE4